BioMed Central Blog
Orphanet Journal of Rare Diseases was recently accepted for tracking by Thomson Reuters. It is included in the ISI Web of Knowledge database and will receive its first impact factor this summer. We are delighted with this
achievement, which confirms the prominence and reputation which Orphanet Journal of Rare Diseases has achieved in its field.
The journal was launched in 2006 and has since published a wide range of open access articles concerning rare diseases and orphan drugs. Overseen by Ségolène Aymé, Bruno Dallapiccola and Dian Donnai, the journal is the official publication of Orphanet, the European portal for rare diseases and orphan drugs.
Orphanet Journal of Rare Diseases is one of eleven BioMed Central titles that are due to receive their first impact factors in June 2008; a full list of all of the BioMed Central journals that are indexed by Thomson Reuters is available from our website.Posted by Charlotte Hubbard at 17:04 Comments (0)
